Production (Stage)
Marker Therapeutics, Inc.
MRKR
$1.77
$0.2516.45%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 20.93% | 27.01% | -48.50% | -56.96% | 76.89% |
Total Receivables | 32.80% | 128.32% | 793.64% | 42.61% | -11.11% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -8.26% | -51.05% | -39.55% | -33.68% | -62.24% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 20.59% | 28.58% | -44.01% | -46.82% | 29.13% |
|
|||||
Total Current Assets | 20.59% | 28.58% | -44.01% | -46.82% | 29.13% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 20.59% | 28.58% | -44.01% | -46.82% | -49.57% |
|
|||||
Total Accounts Payable | 7.94% | 10.93% | 63.43% | -18.65% | -58.03% |
Total Accrued Expenses | 83.54% | 14.92% | 13.74% | -65.20% | -60.54% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -63.38% | -0.10% | -52.11% | 8.62% | 88.81% |
Total Other Current Liabilities | -63.38% | -0.10% | -52.11% | 8.62% | 88.81% |
Total Current Liabilities | 8.58% | 12.67% | 24.51% | -32.48% | -55.73% |
|
|||||
Total Current Liabilities | 8.58% | 12.67% | 24.51% | -32.48% | -55.73% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 8.58% | 12.67% | 24.51% | -32.48% | -80.85% |
|
|||||
Common Stock & APIC | 3.44% | 3.38% | 0.10% | 0.23% | 0.34% |
Retained Earnings | -2.91% | -2.46% | -2.24% | -2.41% | -1.31% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 22.94% | 32.06% | -55.41% | -49.03% | -25.92% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 22.94% | 32.06% | -55.41% | -49.03% | -25.92% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 22.94% | 32.06% | -55.41% | -49.03% | -25.92% |
|